首页> Journal of ethnopharmacology> Efficacy and safety of Qiliqiangxin capsule as adjunctive therapy in heart failure with reduced ejection fraction: A systematic review and meta-analysis of randomized controlled trials.

Efficacy and safety of Qiliqiangxin capsule as adjunctive therapy in heart failure with reduced ejection fraction: A systematic review and meta-analysis of randomized controlled trials.

导出 LinkOut

翻译打印收藏纠错

第一作者： Yuxuan,Li

第一单位： Department of Cardiology, Dongzhimen Hospital, Beijing University of Chinese Medicine, Beijing, China.

作者： Yuxuan,Li ^[1] ; Tianshi,Mao ^[1] ; Xinyan,Qu ^[1] ; Long,Xie ^[1] ; Peng,Li ^[1] ; Bairu,Cheng ^[1] ; Dingyuan,Zhang ^[2] ; Sinai,Li ^[3] ; Dong,Li ^[4] ; Qian,Lin ^[5]

作者单位： Department of Cardiology, Dongzhimen Hospital, Beijing University of Chinese Medicine, Beijing, China. ^[1] Department of Cardiology, Dongfang Hospital, Beijing University of Chinese Medicine, Beijing, China. ^[2] Beijing Hospital of Traditional Chinese Medicine, Capital Medical University, Beijing Institute of Traditional Chinese Medicine, Beijing, China. ^[3] Department of Cardiology, Dongfang Hospital, Beijing University of Chinese Medicine, Beijing, China. Electronic address: dongdong871103@163.com. ^[4] Department of Cardiology, Dongzhimen Hospital, Beijing University of Chinese Medicine, Beijing, China. Electronic address: linqian62@126.com. ^[5]

关键词 Cardiovascular death Heart failure with reduced ejection fraction Hospitalization for heart failure Meta-analysis Traditional Chinese medicine

DOI 10.1016/j.jep.2026.121175

PMID 41500350

发布时间 2026-01-11

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交